BrainCells Alternatives & Competitors
12 companies similar to BrainCells — Pioneering biopharmaceutical solutions to enhance neuron growth and address CNS...
Companies similar to BrainCells
Acadia Pharmaceuticals
Acadia is trailblazing breakthroughs in neuroscience to elevate life.
San Diego, United States
Umecrine Cognition AB
A novel and safe approach for treating cognitive disorders
Solna, Sweden
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful s...
Chicago, United States
Bionomics Ltd
Developing novel drug candidates to transform the lives of patients with anxiety and stres...
Australia
Track all BrainCells competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Alzamend Neuro
Targeting treatment for Alzheimer's Disease, Major Depressive Disorder, Bipolar Disorder,...
Atlanta, United States
Novoron Bioscience
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the...
San Diego, United States
Neurolixis
New treatments for central nervous system disorders
Park Ridge, United States
Rapport Therapeutics
Precision medicines to match the complexity of the human brain.
United States
CNS Therapeutics
Delivering advanced neurological and pain treatments with precision and expertise
Saint Paul, United States
Monument Therapeutics
Bringing Precision Medicine to Neuroscience Drug Development
Macclesfield, United King...
Praxis Precision Medicines, Inc.
The era of genetic neuroscience has arrived
Boston, United States
About BrainCells
BrainCells is a biopharmaceutical company founded in 2003 and headquartered in San Diego, California. The company's slogan - "Pioneering biopharmaceutical solutions to enhance neuron growth and address CNS disorders with advanced clinical-stage programs" - underscores its focus on developing innovative solutions for ce...
Biopharmaceuticals, Neuroscience, Central Nervous System Disorders, Neuron Growth, Clinical-stage Programs, Major Depressive Disorder, Treatment-resistant Depression, Alzheimer's Disease, BCI-838, BCI-632, Synaptic Glutamate, MGlu2/3 Auto-receptor, San Diego, Drug Development, Neurological Disorders
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches BrainCells and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at BrainCells on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
